BRYNOVIN
Active substance: sitagliptin
SOLUTION · SITAGLIPTIN 25 mg/mL
United StatesActive
Marketing holder: Azurity Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- SITAGLIPTIN · 25 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 51 |
|
| EU 14 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-378a-752b-ba2c-f52ee52b6b17,01a120c3-37a6-77c8-8bdf-c65c1cf26623,01a120c3-389d-7ad8-8c3f-e52c5376d328,01a120c3-38e6-7870-9fe1-e62bdd6d25f7,01a120c3-49c6-7464-a5fe-bfcbfabd743e;count=27 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-bcc4-799b-b9cd-0ac4e9a2829e,01a1208c-e836-7876-8ac0-31252f07f1c1,01a1208d-5621-7533-a73b-cd65fca7ed17,01a1208d-a84b-7eb3-9de2-8740f40900f0,01a1208f-55b8-7a49-9744-a8da0e37bbb3;count=36 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 24338-017
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 24338-017 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24338-017 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24338-017 · Verified 2026-10-09 · open in source